In this work, we developed trackable HER2-targeted CAR NK-92 cells co-expressing human NIS that were able to slow the progression of HER2 positive ovarian cancer in mice and could be non-invasively visualized using NIS-targeted PET. Here, ERBB2 is linked to ovarian cancer.